Global Equity in Clinical Trials: An ASCO Policy Statement

Authors

Sana A. Al Sukhun

¹Al Hyatt Oncology Practice, Amman, Jordan

Sana A. Al Sukhun, Verna Vanderpuye, Carolyn Taylor, Abiola Falilat Ibraheem, Andres Wiernik Rodriguez, Fredrick Chite Asirwa, Michael Francisco, Allyn Moushey

Preview

ASCO is a global professional society representing more than 50,000 physicians, other health care professionals, and advocates in over 100 countries specializing in cancer treatment, diagnosis, prevention, and advocacy. ASCO strives, through research, education, and promotion of the highest quality of patient care, to create a world where cancer is prevented or cured, and every survivor is healthy. In this pursuit, health equity remains the guiding institutional principle that applies to all its activities across the cancer care continuum. This ASCO policy statement emphasizes the urgent need for global equity in clinical trials, aiming to enhance access and representation in cancer research as it not only improves cancer outcomes but also upholds principles of fairness and justice in health care.